ZALTRAP Special Drug Use Surveillance (Unresectable advanced and/or recurrent colorectal cancer)
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2018
At a glance
- Drugs Aflibercept (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ZALTRAP
- Sponsors Sanofi K.K.
- 15 Jan 2018 Status changed from not yet recruiting to recruiting.
- 03 Nov 2017 New trial record